These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 30995649)

  • 1. Staphylococcus aureus and Host Immunity in Recurrent Furunculosis.
    Nowicka D; Grywalska E
    Dermatology; 2019; 235(4):295-305. PubMed ID: 30995649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of Staphylococcus aureus toxins and nasal carriage in furuncles and impetigo.
    Durupt F; Mayor L; Bes M; Reverdy ME; Vandenesch F; Thomas L; Etienne J
    Br J Dermatol; 2007 Dec; 157(6):1161-7. PubMed ID: 17916211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Innate and adaptive immune responses against Staphylococcus aureus skin infections.
    Krishna S; Miller LS
    Semin Immunopathol; 2012 Mar; 34(2):261-80. PubMed ID: 22057887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of recurrent furunculosis with Panton-Valentine leukocidin and the genetic background of Staphylococcus aureus.
    Masiuk H; Kopron K; Grumann D; Goerke C; Kolata J; Jursa-Kulesza J; Giedrys-Kalemba S; Bröker BM; Holtfreter S
    J Clin Microbiol; 2010 May; 48(5):1527-35. PubMed ID: 20200289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequencies of PD-1- and PD-L1- positive T CD3
    Nowicka D; Grywalska E; Surdacka A; Grafka A; Roliński J
    Microb Pathog; 2019 Jan; 126():85-91. PubMed ID: 30342909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Host factors that contribute to recurrent staphylococcal skin infection.
    Montgomery CP; David MZ; Daum RS
    Curr Opin Infect Dis; 2015 Jun; 28(3):253-8. PubMed ID: 25887613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Producibility of exfoliative toxin and staphylococcal coagulase types of Staphylococcus aureus strains isolated from skin infections and atopic dermatitis.
    Kanzaki H; Ueda M; Morishita Y; Akiyama H; Arata J; Kanzaki S
    Dermatology; 1997; 195(1):6-9. PubMed ID: 9267729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody responses in furunculosis patients vaccinated with autologous formalin-killed Staphylococcus aureus.
    Holtfreter S; Jursa-Kulesza J; Masiuk H; Verkaik NJ; de Vogel C; Kolata J; Nowosiad M; Steil L; van Wamel W; van Belkum A; Völker U; Giedrys-Kalemba S; Bröker BM
    Eur J Clin Microbiol Infect Dis; 2011 Jun; 30(6):707-17. PubMed ID: 21509478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrent furunculosis: a review of the literature.
    Demos M; McLeod MP; Nouri K
    Br J Dermatol; 2012 Oct; 167(4):725-32. PubMed ID: 22803835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired neutrophil functions in the pathogenesis of an outbreak of recurrent furunculosis caused by methicillin-resistant Staphylococcus aureus among mentally retarded adults.
    Gilad J; Borer A; Smolyakov R; Riesenberg K; Schlaeffer F; Levy R
    Microbes Infect; 2006 Jun; 8(7):1801-5. PubMed ID: 16822690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of common bacterial infections of the skin.
    Bernard P
    Curr Opin Infect Dis; 2008 Apr; 21(2):122-8. PubMed ID: 18317033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What is the role of Staphylococcus aureus and herpes virus infections in the pathogenesis of atopic dermatitis?
    Saintive S; Abad E; C Ferreira D; Stambovsky M; Cavalcante FS; Gonçalves LS; Vidal F; Dos Santos KR
    Future Microbiol; 2017 Nov; 12():1327-1334. PubMed ID: 29052452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrent staphylococcal furunculosis: antibody response against Staphylococcus aureus.
    Espersen F; Hedström SA
    Scand J Infect Dis; 1984; 16(4):413-4. PubMed ID: 6528228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful termination of a furunculosis outbreak due to lukS-lukF-positive, methicillin-susceptible Staphylococcus aureus in a German village by stringent decolonization, 2002-2005.
    Wiese-Posselt M; Heuck D; Draeger A; Mielke M; Witte W; Ammon A; Hamouda O
    Clin Infect Dis; 2007 Jun; 44(11):e88-95. PubMed ID: 17479931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors of recurrent furunculosis.
    El-Gilany AH; Fathy H
    Dermatol Online J; 2009 Jan; 15(1):16. PubMed ID: 19281721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Staphylococcus aureus strategies to evade the host acquired immune response.
    Goldmann O; Medina E
    Int J Med Microbiol; 2018 Aug; 308(6):625-630. PubMed ID: 28939437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sphingomyelinase activity of Staphylococcus aureus strains from recurrent furunculosis and other infections.
    Hedström SA; Malmqvist T
    Acta Pathol Microbiol Immunol Scand B; 1982 Jun; 90(3):217-20. PubMed ID: 6289601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trioleoylglycerol lipolysis by Staphylococcus aureus strains from recurrent furunculosis, pyomyositis, impetigo and osteomyelitis.
    Hedström SA; Nilsson-Ehle P
    Acta Pathol Microbiol Immunol Scand B; 1983 Jun; 91(3):169-73. PubMed ID: 6880741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Innate Immunity to
    Brandt SL; Putnam NE; Cassat JE; Serezani CH
    J Immunol; 2018 Jun; 200(12):3871-3880. PubMed ID: 29866769
    [No Abstract]   [Full Text] [Related]  

  • 20. Adaptive Immunity Against Staphylococcus aureus.
    Karauzum H; Datta SK
    Curr Top Microbiol Immunol; 2017; 409():419-439. PubMed ID: 26919865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.